Clinical Trial Update: HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update shows that HRS-4642 in combination with AG for neoadjuvant and adjuvant treatment of pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AG
• HRS-4642

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING